Salivary Gland Carcinoma

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial [Phase 1]

  This is an early-stage (Phase 1) clinical trial evaluating the combination of DS-8201a (trastuzumab deruxtecan) and AZD6738 (camonsertib) fo…

• CLINICAL_TRIALS research · 2026-04-03
  Clinical Trial Update: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers [Phase 2]

  Phase 2 trial evaluating ado-trastuzumab emtansine versus standard chemotherapy with docetaxel plus trastuzumab or trastuzumab deruxtecan in…

• CLINICAL_TRIALS research · 2026-04-02
  Clinical Trial Update: Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing [Phase 2]

  Phase 2 clinical trial investigating precision treatment guided by molecular typing for recurrent or metastatic salivary gland carcinoma is …

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study [Phase 2]

  Phase 2 open-label cohort study evaluating the safety and efficacy of MRG003, with or without Putrelimab, in recurrent or metastatic salivar…

• CLINICAL_TRIALS research · 2026-03-16
  Clinical Trial Update: Immune Biomarker Study for Salivary Gland Carcinoma

  An ongoing immune biomarker study at University of Erlangen-Nürnberg Medical School is investigating immune biomarkers in salivary gland car…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carcinomas of the Head and Neck Region

  This entry indicates a prospective registry study on implementing simultaneous postoperative radiochemotherapy for locally advanced salivary…

• CLINICAL_TRIALS research · 2026-02-02
  Clinical Trial Update: MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer [Phase 2]

  This clinical trial update reports the Phase 2 study of pemetrexed plus pembrolizumab for recurrent/metastatic salivary gland carcinoma, wit…

• CLINICAL_TRIALS research · 2025-12-31
  Clinical Trial Update: Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma [Phase 2]

  Phase 2 clinical trial evaluating the combination of androgen deprivation therapy and pembrolizumab for advanced androgen receptor–positive …

• CLINICAL_TRIALS research · 2025-12-11
  Clinical Trial Update: VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma [Phase 1, Phase 2]

  Clinical trial update for VMD-928 as a monotherapy and in combination with pembrolizumab to treat TrkA overexpression-driven solid tumors or…

• CLINICAL_TRIALS research · 2018-05-30
  Clinical Trial Update: PSMA-PET Imaging for Advanced ACC/SDC [NA]

  This entry notes the completion of a clinical trial evaluating PSMA-PET imaging in advanced adenoid cystic carcinoma and salivary duct carci…